Get our newsletters

CBP officers seize unapproved PPE and COVID-19 medications


U.S. Customs and Border Protection (CBP) officers in Philadelphia seized 10,000 unapprovcd KN-95 respirator masks Thursday and have continued to seize unapproved COVID-19 medications and related products.

Officers initially examined a shipment of 10 boxes from Israel on May 15 and observed respirator masks that appeared to be of poor quality and packaging. The masks, which were manufactured in China, were destined to an address in Philadelphia. Officers detained the shipment and consulted with U.S. Food and Drug Administration (FDA) inspectors.

FDA inspectors determined that the shipment violated the Federal Food, Drug, and Cosmetic Act, which prohibits the importation of adulterated or misbranded food, drugs, devices, tobacco products, or cosmetics. The manufacturer is also not registered with FDA and does not have an Emergency Use Authorization to import the KN-95 masks.

In addition to these 10,000 unapproved KN-95 face masks, CBP officers at Ports of Entry across the Baltimore Field Office continue to seize shipments of counterfeit and unapproved coronavirus personal protective equipment (PPE) and pharmaceuticals.

Join our readers whose generous donations are making it possible for you to read our news coverage. Help keep local journalism alive and our community strong. Donate today.